Table 4

- Comparison of NOS3 genotype and allele frequency distributions of treatment resistant BD patients with treatment-responsive BD patients and the control groups.

GenotypesTreat. Res.
yes
Treat. Res.
No
OR95% CIP-value
NOS3n=25 (%)n=70 (%)   
b/b12 (48)54 (77.1)3.6561.396-9.575*.007*
b/a11 (44)14 (20)0.318*0.119-0.850*.019*
a/a2 (8)2 (2.9)0.338&0.045-2.540&.282&
Allele     
b35 (55.1)122 (87.1)   
a15 (44.9)18 (12.9)2.905*1.330-6.346*.006*
NOS3 Healthy control   
b/b12 (48)77 (81.1)0.216*0.085-0.551*.001*
b/a11 (44)17 (17.9)3.605*1.397-9.304*.006*
a/a2 (8)1 (1.1)8.174&0.710-94.097&.110&
Allele     
b35 (55.1)171 (63.9)   
a15 (44.9)19 (36.1)0.259*0.120-0.559*.000*

Treat - treatment; Res - resistance; OR - odds ratio; CI - confidence interval,

  • * Pearson chi-square&Fisher’s Exact Test